Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2000;102:2169-2171

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Visioli, F.
Right arrow Articles by Sala, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Visioli, F.
Right arrow Articles by Sala, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*2-PHENYLETHANOL
*PROSTAGLANDIN F2ALPHA
Medline Plus Health Information
*Antioxidants
*Secondhand Smoke
Related Collections
Right arrow Nutrition
Right arrow Oxidant stress
Right arrow Animal models of human disease
Right arrow Risk Factors

(Circulation. 2000;102:2169.)
© 2000 American Heart Association, Inc.


Brief Rapid Communications

Olive Phenol Hydroxytyrosol Prevents Passive Smoking–Induced Oxidative Stress

Francesco Visioli, PhD; Claudio Galli, MD; Elena Plasmati, MS; Serena Viappiani, MS; Alicia Hernandez, PhD; Claudio Colombo, MS; Angelo Sala, PhD

From the University of Milan, Institute of Pharmacological Sciences, Milan, Italy.

Correspondence to Francesco Visioli, PhD, Institute of Pharmacological Sciences, Via Balzaretti 9, 20133 Milan, Italy. E-mail francesco.visioli{at}unimi.it


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Background—Oxidative stress is involved in the onset of several degenerative disorders, and epidemiological studies indicate that a high intake of dietary antioxidants, as in the case of the Mediterranean basin, is protective. Olive mill waste waters (OMWWs) are a byproduct of olive oil production rich in phenolic antioxidants, such as hydroxytyrosol. We tested the effects of a low dose of an OMWW extract in a model of sidestream smoke–induced oxidative stress in rats by evaluating the urinary excretion of 8-iso-prostaglandin (PG) F2{alpha} (iPF2{alpha}-III).

Methods and Results—An OMWW extract (5 mg/kg, providing 414 µg/kg of hydroxytyrosol) was administered to rats daily for 4 days, during which time the animals were exposed to sidestream smoke for 20 minutes once a day. Daily urines were collected, and the urinary excretion of 8-iso-PGF2{alpha} was evaluated as an index of oxidative stress–induced in vivo lipid peroxidation. The exposure of rats to passive smoking increased the urinary excretion of 8-iso-PGF2{alpha} by 44±4.2% at 48 hours and by 55±10% at 96 hours. Treatment with the OMWW extract was able to completely prevent the increase at 48 hours and resulted in lower increments (34±18% versus 55±10%) of 8-iso-PGF2{alpha} excretion at 96 hours.

Conclusions—A low dose of hydroxytyrosol, administered through OMWW, reduces the consequences of sidestream smoke–induced oxidative stress in rats.


Key Words: hydroxytyrosol • isoprostanes • atherosclerosis • smoking • lipids


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMethods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Evidence of the involvement of oxidative stress, resulting in increased lipid peroxidation, in the onset of several diseases is accumulating1 ; epidemiological studies indicate negative correlations between the dietary intake of antioxidants and the incidence of such diseases.2 Appropriate in vivo biomarkers of lipid peroxidation and oxidative stress are scarce, but increased plasma levels and urinary excretion of F2 isoprostanes (a family of prostaglandin [PG] F2{alpha} isomers that is produced from arachidonic acid via free radical–catalyzed mechanisms) are thought to be reflective of enhanced oxidative stress.3

In the Mediterranean area, where the diet is rich in fruits and vegetables and where olive oil is the principal source of fat, the incidence of coronary heart disease is lowest.4 Olive oil is obtained by pressing of the olive fruit, which contains a variety of "minor constituents," most of which are phenolic in nature, that give extra virgin olive oil its particular taste. Such compounds, eg, hydroxytyrosol, have been shown to possess interesting biological activities in vitro.5 During olive oil production, large volumes of water are generated and subsequently discarded; this "waste water" contains notable amounts of relatively polar phenolic compounds, including hydroxytyrosol, whose antioxidant activities have been thoroughly investigated.5 6

Cigarette smoke induces oxidative stress, as reflected by increased circulating levels and urinary excretion of F2-isoprostanes.7 It is noteworthy that passive smoking also increases the risk of heart disease and that experimental evidence indicates that it significantly impairs endothelial function and accelerates atherosclerosis in animals.8 9 It is conceivable that some of the noxious effects of second-hand smoke are due to an enhanced cellular exposure to reactive oxygen species, leading to the formation of lipid peroxidation products, such as isoprostanes, for which various deleterious biological activities have been proposed.3

The present study sought to investigate the effects of an olive mill waste water (OMWW) preparation, of which hydroxytyrosol was the only bioactive component, on the urinary excretion of 8-iso-PGF2{alpha} (iPF2{alpha}-III) in rats exposed to sidestream smoke.


*    Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Methods
down arrowResults
down arrowDiscussion
down arrowReferences
 
Male Sprague-Dawley rats (220 to 250 g), purchased from Charles River (Calco, Italy), were housed in the local animal care facility and were given free access to food and water.

OMWW extracts were prepared from freshly picked olives as previously described.6 High-performance liquid chromatographic analysis6 revealed that the OMWW extract used in the present investigation contained 26.7% (wt/wt) phenolic compounds, of which 31% (as evaluated by comparison with an authentic standard) was hydroxytyrosol. The individual components were separated and collected, and their antioxidant capacity was evaluated in a model of copper sulfate–oxidized LDL.10 The results demonstrated that only hydroxytyrosol was able to inhibit LDL oxidation (not shown).

The extract was dissolved in ethanol and was administered to the rats by gavage between 9:00 and 9:30 AM (5% ethanol, ie, 50 µL/rat). Control groups were given 5% ethanol in water.

Experimental Protocols
Animals were randomly assigned to 2 experimental groups. The first group (n=6) was given the OMWW extract (5 mg/kg, once a day, ie, 414 µg · kg-1 · d-1 of hydroxytyrosol), and the second (n=6) the vehicle alone. Rats received the treatments for 2 days, after which they were exposed daily for 4 days to sidestream smoke as described below, 15 minutes after receiving the compounds under investigation. Every other day (days 0, 2, and 4 after beginning of smoking), rats were placed in metabolic cages, with free access to food and tap water, for the collection of urines. Twenty-four-hour urines were collected in the morning and stored at -80°C.

Exposure of Rats to Passive Smoke
Rats were placed in a sealed Plexiglas box that was filled with smoke from 1 cigarette (nicotine 1.2 mg, tar 12 mg); the animals were kept in the smoke-filled chamber for 1 exposure of 20 minutes’ duration. The average CO volume in the box during the smoke exposure was 0.26±0.05%, as measured by a CO detector tube (Auergesellschaft GmbH).11

At the end of the treatment, the rats were returned either to their cage or to a metabolic cage for the collection of 24-hour urine.

Evaluation of 8-iso-PGF2{alpha} Urinary Excretion
Urinary 8-iso-PGF2{alpha} was purified by a double-extraction method according to Wang et al,12 with modifications,13 followed by quantification by an enzyme immunoassay. Acetylcholine esterase tracer was obtained from Cayman Chemical, and the specific antibody was kindly provided by the late Dr J. Maclouf (Hopital Lariboisiere, Paris). Urinary creatinine concentrations were measured with a commercial kit (Sigma Chemical Co). Results were corrected for the recovery of radiolabeled tracer and expressed as pg/mg creatinine. Unless stated otherwise, data were expressed as mean±SEM of 6 observations, and comparisons were performed by use of the Wilcoxon rank sum test.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
*Results
down arrowDiscussion
down arrowReferences
 
The urinary excretion of 8-iso-PGF2{alpha} under basal conditions averaged 264±82 pg/mg creatinine (mean±SD, n=12) and was not significantly different between controls and OMWW-treated rats. Levels of 8-iso-PGF2{alpha} in urines of nontreated rats after 2 exposures to sidestream smoke rose from 237±34 to 319±35 pg/mg creatinine (n=6), ie, an increase of 82±46 pg/mg creatinine (Figure 1ADown), or 44±4.2% (Figure 1BDown, P<0.05), over presmoking levels. Treatment with the OMWW extract completely prevented this increase, with urinary excretion averaging 291±32 pg/mg creatinine before and 287±66 pg/mg creatinine after 2 exposures to sidestream smoke (n=6), ie, a decrease of 4±45 pg/mg creatinine (Figure 1ADown), or 6.8±4.3% (Figure 1BDown), P=NS versus presmoking values. When control rats were exposed to sidestream smoke 4 times, the urinary excretion of 8-iso-PGF2{alpha} was 375±58 pg/mg creatinine, ie, an increase of 145±33 pg/mg creatinine (Figure 1ADown, P<0.05), or 55±10% (Figure 1BDown, P<0.01), over presmoking levels. Antioxidant treatment attenuated this increase to 84±51 pg/mg creatinine (Figure 1ADown, P=NS), ie, 34±18% (Figure 1BDown, P=NS), over presmoking levels, resulting in a mean 8-iso-PGF2{alpha} excretion in this group of 375±51 pg/mg creatinine (n=6).



View larger version (29K):
[in this window]
[in a new window]
 
Figure 1. Passive smoking and urinary excretion of 8-iso-PGF2{alpha} (iPF2{alpha}-III) in rats. Increase in urinary excretion of 8-iso-PGF2{alpha} is expressed either as pg/mg creatinine (A) or as percent increase over presmoking values (B). *P<0.05, **P<0.01, unpaired data analysis, Wilcoxon rank sum test. WW indicates OMWW.


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
*Discussion
down arrowReferences
 
The data reported in this article demonstrate that an OMWW extract, the main antioxidant component of which is hydroxytyrosol, decreases oxidative stress in rats exposed to sidestream smoke.

Passive smoking is known to induce several effects normally associated with active smoking. For example, we have previously observed an increase in bronchial reactivity in animals exposed to passive smoking,11 and we are now reporting that repeated exposure of rats to sidestream smoke results in a significant elevation of urinary excretion of 8-iso-PGF2{alpha} (iPF2{alpha}-III), a reliable marker of oxidative stress in vivo.3 Furthermore, enhanced urinary excretion of 8-iso-PGF2{alpha} has been reported in smokers as well as in different pathologies associated with increased levels of oxidative stress.7 14 In particular, an increase in 8-iso-PGF2{alpha} urinary excretion has been reported in patients suffering from chronic obstructive pulmonary disease, in whom a significant correlation with inflammation and respiratory functions was also observed.15 The increase in the urinary excretion of 8-iso-PGF2{alpha}, evaluated semiquantitatively by immunoassay, after 2 and 4 days of passive smoking in rats reported here suggests that enhanced oxidative stress represents an immediate-early feature of the inflammatory response associated with lung exposure to smoke components, although we cannot rule out the possibility that other, cyclooxygenase-derived, compounds might be detected by this assay and contribute to the high interindividual variability observed.

It is noteworthy that the OMWW extract used in this study contained 8.3% hydroxytyrosol as the active antioxidant compound and therefore, the actual dose of hydroxytyrosol administered to the laboratory animals was only 414 µg · kg-1 · d-1. In a recent study using apoE-deficient mice, vitamin E decreased isoprostane, ie, iPF2{alpha}-VI, levels at an estimated dose of {approx}270 mg · kg-1 · d-116 ; although experimental conditions were different in the 2 studies, our results suggest that the hydroxytyrosol present in OMWW extracts is very effective in decreasing the oxidative stress associated with passive cigarette smoke. The amphiphilic nature of this compound, as opposed to the lipophilic characteristics of vitamin E, might provide an additional protection against oxidative processes that take place in biological systems at the water-lipid interface.

Evidence of a dose-dependent absorption of hydroxytyrosol in humans was recently obtained in our laboratory17 ; the present investigation indicates that hydroxytyrosol retains its antioxidant activity in vivo, and additional work is needed to evaluate its potential activity in humans.


*    Acknowledgments
 
This study was supported in part by EEC grant FAIR CT 97 3039 and by MURST-Progetti di Ricerca di Interesse Nazionale 1998 (to Dr Sala). The OMWW extract was prepared by Drs F.F. Vincieri, A. Romani, and N. Mulinacci (University of Florence) and Drs P.G. Pifferi and L. Setti (University of Bologna). Drs E. DePaoli and R. Prugger (Tecnoalimenti, Milan) assisted with the collection of olives. Dr Balz Frei critically revised the manuscript.

Received August 17, 2000; revision received August 31, 2000; accepted August 31, 2000.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMethods
up arrowResults
up arrowDiscussion
*References
 

  1. Halliwell B. Antioxidants and human disease: a general introduction. Nutr Rev. 1997;55:S44–S49.[Medline] [Order article via Infotrieve]
  2. Hertog MGL, Feskens EJM, Hollman PCH, et al. Dietary antioxidant flavonoids and risk of coronary heart disease. The Zutphen elderly study. Lancet. 1993;342:1007–1011.[Medline] [Order article via Infotrieve]
  3. Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidation stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol. 1997;17:2309–2315.[Abstract/Free Full Text]
  4. Keys A. Mediterranean diet and public health: personal reflections. Am J Clin Nutr. 1995;61:1321S–1323S.[Abstract]
  5. Visioli F, Galli C. The effect of minor constituents of olive oil on cardiovascular disease: new findings. Nutr Rev. 1998;56:142–147.[Medline] [Order article via Infotrieve]
  6. Visioli F, Romani A, Mulinacci N, et al. Antioxidant and other biological activities of olive mill waste waters. J Agric Food Chem. 1999;47:3397–3401.[Medline] [Order article via Infotrieve]
  7. Morrow J, Frei B, Longmire AW, et al. Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. N Engl J Med. 1995;332:1198–1203.[Abstract/Free Full Text]
  8. Celermajer DS, Adams MR, Clarkson P, et al. Passive smoking and impaired endothelium-dependent arterial dilatation in healthy young adults. N Engl J Med. 1996;334:150–155.[Abstract/Free Full Text]
  9. Zhu B-Q, Sun Y-P, Sievers RE, et al. Passive smoking increases experimental atherosclerosis in cholesterol-fed rabbits. J Am Coll Cardiol. 1993;21:225–232.[Abstract]
  10. Visioli F, Bellomo G, Montedoro G, et al. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis. 1995;117:25–32.[Medline] [Order article via Infotrieve]
  11. Omini C, Hernandez A, Zuccari G, et al. Passive cigarette smoke exposure induces airway hyperreactivity to histamine but not to acetylcholine in guinea-pigs. Pulm Pharmacol. 1990;3:145–150.[Medline] [Order article via Infotrieve]
  12. Wang Z, Ciabattoni G, Creminon C, et al. Immunological characterization of urinary 8-epi-prostaglandin F2{alpha} excretion in man. J Pharmacol Exp Ther. 1995;275:94–100.[Abstract/Free Full Text]
  13. Sautebin L, Ianaro A, Rombolà L, et al. Cyclooxygenase-2-dependent generation of 8-epi-prostaglandin F2{alpha} by lipopolysaccharide-activated J774 macrophages. Inflamm Res. 1999;48:503–508.[Medline] [Order article via Infotrieve]
  14. Davi G, Alessandrini P, Mezzetti A, et al. In vivo formation of 8-epi-prostaglandin-F2{alpha} is increased in hypercholesterolemia. Arterioscler Thromb Vasc Biol. 1997;17:3230–3235.[Abstract/Free Full Text]
  15. Praticó D, Basili S, Vieri M, et al. Chronic obstructive pulmonary disease is associated with an increase in urinary levels of isoprostane F2alpha-III, an index of oxidant stress. Am J Respir Crit Care Med. 1998;158:1709–1714.[Abstract/Free Full Text]
  16. Praticó D, Tangirala RK, Rader DJ, et al. Vitamin E suppresses isoprostane generation in vivo and reduces atherosclerosis in apoE-deficient mice. Nat Med. 1998;4:1189–1192.[Medline] [Order article via Infotrieve]
  17. Visioli F, Galli C, Bornet F, et al. Olive oil phenolics are dose-dependently absorbed in humans. FEBS Lett. 2000;468:159–160.[Medline] [Order article via Infotrieve]



This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. A. Carluccio, M. A. Ancora, M. Massaro, M. Carluccio, E. Scoditti, A. Distante, C. Storelli, and R. De Caterina
Homocysteine induces VCAM-1 gene expression through NF-{kappa}B and NAD(P)H oxidase activation: protective role of Mediterranean diet polyphenolic antioxidants
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2344 - H2354.
[Abstract] [Full Text] [PDF]


Home page
Hum Exp ToxicolHome page
I. Basyigit, M. Tugay, M.O. Dilioglugil, F. Yildiz, H. Maral, and S. Sozubir
Protective effects of N-acetylcysteine on peroxidative changes of the fetal rat lungs whose mothers were exposed to cigarette smoke
Human and Experimental Toxicology, February 1, 2007; 26(2): 99 - 103.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
M.-I. Covas, K. Nyyssonen, H. E. Poulsen, J. Kaikkonen, H.-J. F. Zunft, H. Kiesewetter, A. Gaddi, R. de la Torre, J. Mursu, H. Baumler, et al.
The effect of polyphenols in olive oil on heart disease risk factors: a randomized trial.
Ann Intern Med, September 5, 2006; 145(5): 333 - 341.
[Abstract] [Full Text] [PDF]


Home page
J BiochemHome page
S. Acin, M. A. Navarro, J. M. Arbones-Mainar, N. Guillen, A. J. Sarria, R. Carnicer, J. C. Surra, I. Orman, J. C. Segovia, R. d. l. Torre, et al.
Hydroxytyrosol Administration Enhances Atherosclerotic Lesion Development in Apo E Deficient Mice
J. Biochem., September 1, 2006; 140(3): 383 - 391.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
T. Raupach, K. Schafer, S. Konstantinides, and S. Andreas
Secondhand smoke as an acute threat for the cardiovascular system: a change in paradigm
Eur. Heart J., February 2, 2006; 27(4): 386 - 392.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
C. M. Bitler, T. M. Viale, B. Damaj, and R. Crea
Hydrolyzed Olive Vegetation Water in Mice Has Anti-Inflammatory Activity
J. Nutr., June 1, 2005; 135(6): 1475 - 1479.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. Barnoya and S. A. Glantz
Cardiovascular Effects of Secondhand Smoke: Nearly as Large as Smoking
Circulation, May 24, 2005; 111(20): 2684 - 2698.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
P. Santus, A. Sola, P. Carlucci, F. Fumagalli, A. Di Gennaro, M. Mondoni, C. Carnini, S. Centanni, and A. Sala
Lipid Peroxidation and 5-Lipoxygenase Activity in Chronic Obstructive Pulmonary Disease
Am. J. Respir. Crit. Care Med., April 15, 2005; 171(8): 838 - 843.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
T. Weinbrenner, M. Fito, R. d. l. Torre, G. T. Saez, P. Rijken, C. Tormos, S. Coolen, M. F. Albaladejo, S. Abanades, H. Schroder, et al.
Olive Oils High in Phenolic Compounds Modulate Oxidative/Antioxidative Status in Men
J. Nutr., September 1, 2004; 134(9): 2314 - 2321.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
F. Visioli, C. Galli, S. Grande, K. Colonnelli, C. Patelli, G. Galli, and D. Caruso
Hydroxytyrosol Excretion Differs between Rats and Humans and Depends on the Vehicle of Administration
J. Nutr., August 1, 2003; 133(8): 2612 - 2615.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
E. Miro-Casas, M.-I. Covas, M. Farre, M. Fito, J. Ortuno, T. Weinbrenner, P. Roset, and R. de la Torre
Hydroxytyrosol Disposition in Humans
Clin. Chem., June 1, 2003; 49(6): 945 - 952.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. A. Carluccio, L. Siculella, M. A. Ancora, M. Massaro, E. Scoditti, C. Storelli, F. Visioli, A. Distante, and R. De Caterina
Olive Oil and Red Wine Antioxidant Polyphenols Inhibit Endothelial Activation: Antiatherogenic Properties of Mediterranean Diet Phytochemicals
Arterioscler. Thromb. Vasc. Biol., April 1, 2003; 23(4): 622 - 629.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
K. L. Tuck, M. P. Freeman, P. J. Hayball, G. L. Stretch, and I. Stupans
The In Vivo Fate of Hydroxytyrosol and Tyrosol, Antioxidant Phenolic Constituents of Olive Oil, after Intravenous and Oral Dosing of Labeled Compounds to Rats
J. Nutr., July 1, 2001; 131(7): 1993 - 1996.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Visioli, F.
Right arrow Articles by Sala, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Visioli, F.
Right arrow Articles by Sala, A.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*2-PHENYLETHANOL
*PROSTAGLANDIN F2ALPHA
Medline Plus Health Information
*Antioxidants
*Secondhand Smoke
Related Collections
Right arrow Nutrition
Right arrow Oxidant stress
Right arrow Animal models of human disease
Right arrow Risk Factors